Triple Hair’s Feature in the NY Post
Triple Hair is pleased to share that its proof-of-concept trial results have been featured in the New York Post. The article, titled “New triple-threat topical treatment fights hair loss better than finasteride and minoxidil,” highlights the promising findings from our TH-07 research- read the full article her
Read the full publication here: https://nypost.com/2026/03/16/health/triple-threat-fights-hair-loss-better-than-finasteride-and-minoxidil/
About Triple Hair
Triple Hair Group Inc. is a Canadian biotechnology company specializing in developing innovative treatments for men and women suffering from alopecia. Its mission is to provide the underserved market with clinically proven and efficient prescription and over-the-counter treatments for hair regrowth.
The Company also sells its drug-free patented products for preventing hair loss and regaining hair density in mild to moderate cases of alopecia under the brands RIZNTM (www.rizn.ca) for men, and Plenty NaturalTM(www.plentynatural.ca) for women. RIZNTM and Plenty NaturalTM allow hair loss sufferers in their early stages to access effective and natural hair growth solutions without a prescription easily.
For more information, visit the Company’s website, at www.triplehair.ca/investors.